Invention Grant
US08389247B2 Physiogenomic method for predicting diabetes and metabolic syndromes induced by psychotropic drugs
失效
用于预测精神药物引起的糖尿病和代谢综合征的生理基因组学方法
- Patent Title: Physiogenomic method for predicting diabetes and metabolic syndromes induced by psychotropic drugs
- Patent Title (中): 用于预测精神药物引起的糖尿病和代谢综合征的生理基因组学方法
-
Application No.: US13195116Application Date: 2011-08-01
-
Publication No.: US08389247B2Publication Date: 2013-03-05
- Inventor: Gualberto Ruano , Andreas Windemuth , John W. Goethe
- Applicant: Gualberto Ruano , Andreas Windemuth , John W. Goethe
- Applicant Address: US CT Hartford
- Assignee: Genomas, Inc.
- Current Assignee: Genomas, Inc.
- Current Assignee Address: US CT Hartford
- Agency: Cantor Colburn LLP
- Main IPC: C12P19/34
- IPC: C12P19/34
Abstract:
The invention is generally directed to a physiogenomic method for predicting diabetes and metabolic syndromes induced by psychotropic drugs. In one embodiment, the invention relates to the use of genetic variants of marker genes to predict the likelihood that an individual will experience undesirable metabolic side effects as a result of the use of a drug including, but not limited to, psychotropic drugs. The invention also relates to methods predicting the likelihood of diabetes and metabolic syndromes induced by the use of drugs with undesirable metabolic side effects.
Public/Granted literature
- US20110312508A1 PHYSIOGENOMIC METHOD FOR PREDICTING DIABETES AND METABOLIC SYNDROMES INDUCED BY PSYCHOTROPIC DRUGS Public/Granted day:2011-12-22
Information query
